You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
康希诺/联邦制药/威高股份急涨10%-12% 後者再创纪录高
阿思达克 07-22 14:11
本月初获野村升价至21.9元及重申「买入」的威高股份(01066.HK)反覆探顶,今天股价突破上周五所创纪录高位20.25元,最高见21.6元,现造21.25元,续涨12%,成交已较昨天全日高近八成至3,327万股,涉资6.95亿元。

全球三种领先候选新冠肺炎疫苗公布积极进展,其中军事科学院与康希诺生物(06185.HK)研发疫苗在列。此外,美国总统特朗普声称愿意与中国或其他国家合作,将有效新冠病毒疫苗带到美国。

康希诺股价三连涨,今天重越20天及10天线(222.08元及225.64元),最高238元,现造233元,续涨逾10%,成交额5.96亿元。此外,上月下旬遭控股东以每股7.24元配售公司1.08亿股的联邦制药(03933.HK)升破20天、10天及50天线(7-7.2元),最高见7.82元,现造7.76元,急弹11%,成交增至1,945万股,涉资1.459亿元。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account